The board (the "Board") of directors (the "Directors") of Vincent Medical Holdings Limited announced that the Group had recently received Emergency Use Authorization ("EUA") from the Food and Drug Administration of the United States ("FDA") for Inspired TM heat and moisture exchanging filter (the "HMEF") and bacterial/viral respirator filter (the "Bacterial/Viral Filter") (collectively the "Filters") and HypnusTM positive airway pressure device 8 series (the "PAP 8 Series"). The Filters are medical consumables (for single patient use only and are required to be replaced every 24 hours) that serves as a key component for non-active breathing circuits for use with ventilators, anesthesia machines and open flow systems where filtration of inspired and/or expired gases is desired, so as to prevent cross contamination. For HMEF, also known as "artificial nose", it can maintain moisture levels in the patient's respiratory tract during anesthesia, artificial respiration and other types of assisted ventilation. The Filters were approved by the Japan's Ministry of Health, Labour and Welfare and the National Medical Products Administration (the "NMPA") of the People's Republic of China and with the Conformité Européenne (CE) Mark. AutoMedx, LLC, a company in the United States of America, is the distributor for the Filters in the United States of America. The PAP 8 Series is indicated to provide non-invasive positive airway pressure to spontaneously breathing patients weighing over 30 kg with Obstructive Sleep Apnea, and BPAP-T mode and BPAP-ST mode can be used for respiratory insufficiency. It is intended for hospital and home use and is not intended for patients dependent on mechanical ventilation. The PAP 8 Series was approved by the NMPA and with CE Mark.